GlassScriptPhysician profile
Paige K Fairhead
NPI 1013446004
$2,380.36
in general payments reported to CMS, 2019-2025
26 companies · $422 in 2025
The $422 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $166 · 2022: $619 · 2023: $502 · 2024: $672 · 2025: $422.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,595.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,595.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $629.51 | 2023-2025 | Veozah, Myrbetriq |
| Abbvie INC. | $388.52 | 2021-2023 | |
| Sumitomo Pharma America, INC. | $192.06 | 2023-2025 | Myfembree |
| Mayne Pharma Commercial LLC | $167.30 | 2022-2025 | |
| Exeltis, USA INC. | $149.40 | 2021-2025 | Slynd |
| Organon LLC | $143.80 | 2022-2025 | Nexplanon |
| Coopersurgical, INC. | $88.11 | 2022-2025 | Paragard T 380a, Paragard T 380a |
| Biogen, INC. | $80.82 | 2024 | Zurzuvae |
| Biohaven Pharmaceutical Holding Company LTD. | $74.06 | 2022 | |
| Myovant Sciences INC. | $63.89 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $60.85 | 2021-2023 | |
| Daiichi Sankyo INC. | $57.91 | 2022-2023 | Injectafer |
| Hologic Sales and Service, LLC | $48.63 | 2024-2025 | Novasure, Acessa Provu System, Coolseal Generator |
| Pfizer INC. | $40.82 | 2022-2023 | |
| Octapharma USA, INC. | $28.83 | 2025 | Fibryga |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Therapeuticsmd, INC. | $18.67 | 2021 | |
| Merck Sharp & Dohme LLC | $18.61 | 2023 | Gardasil 9 |
| Baxter Healthcare | $17.51 | 2022 | |
| Novo Nordisk INC | $17.12 | 2025 | |
| Medtronic, INC. | $15.55 | 2022 | |
| Smith+Nephew, INC. | $13.79 | 2025 | Pico |
| Boehringer Ingelheim Pharmaceuticals, INC. | $13.57 | 2021 | |
| Agile Therapeutics, INC. | $13.22 | 2022 | |
| Biohaven Pharmaceuticals, INC. | $13.15 | 2021 | |
| Pharmacosmos Therapeutics INC. | $12.90 | 2023 | Monoferric |
| Amgen INC. | $11.76 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Paige Fairhead listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.